Dr. John Lehr, MD

NPI: 1447211289
Total Payments
$63,657
2024 Payments
$156.12
Companies
26
Transactions
141
Medicare Patients
10,578
Medicare Billing
$2.9M

Payment Breakdown by Category

Consulting$58,135 (91.3%)
Research$2,871 (4.5%)
Food & Beverage$2,526 (4.0%)
Other$125.00 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $58,135 26 91.3%
Unspecified $2,871 1 4.5%
Food and Beverage $2,526 113 4.0%
Honoraria $125.00 1 0.2%

Payments by Type

General
$60,786
140 transactions
Research
$2,871
1 transactions

Top Paying Companies

Company Total Records Latest Year
Baxter Healthcare $51,075 24 $0 (2023)
Welch Allyn $7,185 3 $0 (2019)
Allergan, Inc. $3,060 18 $0 (2021)
Regeneron Healthcare Solutions, Inc. $403.61 14 $0 (2024)
ABBVIE INC. $269.84 16 $0 (2024)
Alimera Sciences, Inc. $228.19 16 $0 (2023)
Sun Pharmaceutical Industries Inc. $180.76 5 $0 (2020)
Novartis Pharmaceuticals Corporation $152.30 8 $0 (2021)
Alcon Vision LLC $150.75 1 $0 (2023)
Bausch & Lomb Americas Inc. $142.16 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $156.12 7 Astellas Pharma US Inc ($52.66)
2023 $33,867 37 Baxter Healthcare ($32,990)
2022 $18,489 34 Baxter Healthcare ($18,085)
2021 $386.81 20 Allergan, Inc. ($89.75)
2020 $241.36 8 Regeneron Pharmaceuticals, Inc. ($112.85)
2019 $6,382 13 Welch Allyn ($6,210)
2018 $1,063 7 Welch Allyn ($975.00)
2017 $3,073 15 Allergan Inc. ($2,920)

All Payment Transactions

141 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
11/07/2024 Regeneron Healthcare Solutions, Inc. EYLEA HD (Biological), EYLEA Food and Beverage In-kind items and services $13.79 General
Category: OPHTHALMOLOGY
09/12/2024 ABBVIE INC. OZURDEX (Drug) Food and Beverage In-kind items and services $21.84 General
Category: EYE CARE
08/14/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $24.10 General
Category: Ophthalmology
05/10/2024 ABBVIE INC. OZURDEX (Drug) Food and Beverage In-kind items and services $28.10 General
Category: EYE CARE
04/17/2024 Bausch & Lomb Americas Inc. XIPERE (Drug) Food and Beverage In-kind items and services $18.60 General
Category: Ophthalmology
03/28/2024 Apellis Pharmaceuticals, Inc. Syfovre (Drug) Food and Beverage In-kind items and services $21.13 General
Category: Ophthalmology
03/15/2024 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $28.56 General
Category: Ophthalmology
12/08/2023 Baxter Healthcare Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network Consulting Fee Cash or cash equivalent $3,225.00 General
Category: Physical Assessment, Vision
11/29/2023 RxSight Inc RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE Food and Beverage In-kind items and services $138.55 General
Category: OPHTHALMOLOGY
11/15/2023 Baxter Healthcare Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network Consulting Fee Cash or cash equivalent $4,100.00 General
Category: Physical Assessment, Vision
11/03/2023 Regeneron Healthcare Solutions, Inc. EYLEA HD (Biological) Food and Beverage In-kind items and services $36.07 General
Category: OPHTHALMOLOGY
11/03/2023 Regeneron Healthcare Solutions, Inc. EYLEA HD (Biological) Food and Beverage In-kind items and services $1.02 General
Category: OPHTHALMOLOGY
11/02/2023 Alimera Sciences, Inc. ILUVIEN (Drug) Food and Beverage Cash or cash equivalent $23.57 General
Category: OPHTHALMOLOGY
10/13/2023 Baxter Healthcare Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network Consulting Fee Cash or cash equivalent $3,585.00 General
Category: Physical Assessment, Vision
09/15/2023 Apellis Pharmaceuticals, Inc. Syfovre (Drug) Food and Beverage Cash or cash equivalent $23.32 General
Category: Ophthalmology
09/12/2023 ABBVIE INC. OZURDEX (Drug) Food and Beverage In-kind items and services $22.33 General
Category: EYE CARE
09/11/2023 Bausch & Lomb Americas Inc. XIPERE (Drug) Food and Beverage In-kind items and services $23.39 General
Category: Ophthalmology
09/11/2023 Bausch & Lomb Americas Inc. XIPERE (Drug) Food and Beverage In-kind items and services $21.46 General
Category: Ophthalmology
09/08/2023 Baxter Healthcare Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network Consulting Fee Cash or cash equivalent $2,555.00 General
Category: Physical Assessment, Vision
09/02/2023 Astellas Pharma US Inc Food and Beverage In-kind items and services $26.18 General
08/31/2023 Genentech USA, Inc. Vabysmo (Drug) Food and Beverage In-kind items and services $22.22 General
Category: Immunology and Ophthalmology
08/18/2023 Regeneron Healthcare Solutions, Inc. EYLEA (Biological) Food and Beverage In-kind items and services $30.71 General
Category: OPHTHALMOLOGY
08/11/2023 Baxter Healthcare Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network Consulting Fee Cash or cash equivalent $2,770.00 General
Category: Physical Assessment, Vision
07/24/2023 Baxter Healthcare Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network Consulting Fee Cash or cash equivalent $4,070.00 General
Category: Physical Assessment, Vision
06/22/2023 Johnson & Johnson Surgical Vision, Inc. Tecnis IOL (Device), Tecnis IOL, Tecnis IOL Food and Beverage In-kind items and services $21.18 General
Category: Optics

Research Studies & Clinical Trials

Study Name Company Amount Records
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration Allergan Inc. $2,871 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 2,371 9,659 $1.8M $647,765
2022 12 2,941 7,029 $2.2M $700,874
2021 14 2,820 6,792 $2.6M $806,594
2020 14 2,446 6,287 $3.4M $701,555
Total Patients
10,578
Total Services
29,767
Medicare Billing
$2.9M
Procedure Codes
50

All Medicare Procedures & Services

50 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0178 Injection, aflibercept, 1 mg Office 2023 69 412 $824,000 $284,556 34.5%
J2777 Injection, faricimab-svoa, 0.1 mg Office 2023 22 4,920 $187,255 $142,890 76.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 581 913 $182,600 $83,046 45.5%
67028 Injection of drug into eye Office 2023 173 621 $226,100 $53,084 23.5%
92134 Imaging of retina Office 2023 625 1,486 $148,600 $43,341 29.2%
J7999 Compounded drug, not otherwise classified Office 2023 101 309 $63,100 $20,115 31.9%
92201 Extended exam of the back part of the eye with retinal drawing Office 2023 367 441 $132,300 $8,005 6.1%
92202 Extended exam of the back part of the eye with optic nerve drawing Office 2023 366 490 $49,000 $5,661 11.6%
92235 Exam of retinal blood vessels using a special camera after injection of a dye Office 2023 34 34 $10,500 $3,537 33.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 33 33 $9,900 $3,530 35.7%
J0178 Injection, aflibercept, 1 mg Office 2022 81 524 $1.0M $376,630 35.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 657 1,020 $204,000 $90,391 44.3%
67028 Injection of drug into eye Office 2022 218 757 $341,100 $63,431 18.6%
92134 Imaging of retina Office 2022 727 1,684 $168,400 $48,413 28.7%
J2778 Injection, ranibizumab, 0.1 mg Office 2022 12 162 $164,430 $35,920 21.8%
J2777 Injection, faricimab-svoa, 0.1 mg Office 2022 12 960 $36,538 $28,645 78.4%
J7999 Compounded drug, not otherwise classified Office 2022 134 374 $37,400 $24,380 65.2%
92202 Extended exam of the back part of the eye with optic nerve drawing Office 2022 555 876 $87,600 $10,351 11.8%
92201 Extended exam of the back part of the eye with retinal drawing Office 2022 391 518 $114,200 $9,342 8.2%
92235 Exam of retinal blood vessels using a special camera after injection of a dye Office 2022 73 73 $21,900 $6,960 31.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 57 57 $17,100 $5,706 33.4%
92250 Photography of the retina Office 2022 24 24 $3,600 $704.60 19.6%
J0178 Injection, aflibercept, 1 mg Office 2021 68 482 $964,000 $353,629 36.7%
J2778 Injection, ranibizumab, 0.1 mg Office 2021 25 485 $484,155 $123,079 25.4%
J0179 Injection, brolucizumab-dbll, 1 mg Office 2021 13 325 $189,586 $81,250 42.9%

About Dr. John Lehr, MD

Dr. John Lehr, MD is a Retina Specialist healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447211289.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Lehr, MD has received a total of $63,657 in payments from pharmaceutical and medical device companies, with $156.12 received in 2024. These payments were reported across 141 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($58,135).

As a Medicare-enrolled provider, Lehr has provided services to 10,578 Medicare beneficiaries, totaling 29,767 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.

Practice Information

  • Specialty Retina Specialist
  • Other Specialties Ophthalmology
  • Location Orlando, FL
  • Active Since 03/31/2006
  • Last Updated 09/13/2024
  • Taxonomy Code 207WX0107X
  • Entity Type Individual
  • NPI Number 1447211289

Products in Payments

  • Hillrom - RetinaVue 700 Imager (Device) $51,075
  • RetinaVue Network (Device) $6,335
  • RetinaVue 100 Imager (Device) $850.00
  • EYLEA (Biological) $441.67
  • OZURDEX (Drug) $323.80
  • Clareon (Device) $150.75
  • XIPERE (Drug) $142.16
  • BEOVU (Drug) $140.82
  • RXSIGHT CONTACT LENS (Device) $138.55
  • Iluvien (Drug) $113.02
  • Bromsite (Drug) $100.00
  • ILUVIEN (Drug) $78.55
  • DURYSTA (Drug) $74.52
  • CEQUA (Drug) $62.41
  • VABYSMO (Drug) $62.12
  • Izervay (Drug) $52.66
  • Omidria (Drug) $52.54
  • EYLEA HD (Biological) $50.88
  • Tecnis IOL (Device) $50.56
  • Syfovre (Drug) $44.45

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Retina Specialist Doctors in Orlando